The concerns raised in that process tend to cluster around a few themes: whether the substance can be reliably identified and characterized for purity, whether there is adequate human safety data, and whether the historical use supports the proposed compounding use
Mothers with a deficiency often birth babies with deficiencies, too
(Sermorelin is FDA approved for use in children with pituitary issues.) The World Anti-Doping Agency has banned BPC-157 and any growth-hormone-releasing peptides, too, which means no athlete competing in a drug-tested sport should go near them
Virology 537 , 254262 (2019)
*Correspondence: Weici Wang [email protected] Ye [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Infectious Diseases - Surveillance, Prevention and Treatment, a section of the journal Frontiers in Public Health Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
